Design and rationale of the ATHENA study – A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial

BACKGROUND: Immunosuppression with calcineurin inhibitors remains the mainstay of treatment after kidney transplantation; however, long-term use of these drugs may be associated with nephrotoxicity. In this regard, the current approach is to optimise available immunosuppressive regimens to reduce th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerer, Claudia, Suwelack, Barbara, Dragun, Duska, Schenker, Peter, Hauser, Ingeborg A., Nashan, Björn, Thaiss, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756406/
https://www.ncbi.nlm.nih.gov/pubmed/26888217
http://dx.doi.org/10.1186/s13063-016-1220-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756406/
https://www.ncbi.nlm.nih.gov/pubmed/26888217
http://dx.doi.org/10.1186/s13063-016-1220-9

Ejemplares similares